Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors
Clinical trial NCT02450136 · COMPLETED
Trial details
- NCT number
- NCT02450136
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-08
- Primary completion
- 2017-07-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.